Are you Jaron E. Mark, M.D.? This profile is yours to edit: update your address, phone, photo and services.
Edit this profileJaron E. Mark, M.D. is a healthcare provider in San Antonio, TX specializing in gynecological oncology. Jaron trained at Meharry Medical College School of Medicine, graduating in 2012. Jaron is also listed as specializing in gynecologic oncology. Medicare claims data shows Jaron provided 1,827 services to 283 patients. The services billed most often include injection, dexamethasone sodium phosphate, 1 mg, infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less, and blood test, comprehensive group of blood chemicals. This provider record is associated with NPI 1073888319.
Factual summary compiled by Guide.md from public records; not written by this provider.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
4383 MEDICAL DR
San Antonio, TX 78229
1,827 services · 283 patients · 14 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Insertion of needle into vein for collection of blood sample | Procedure | 36415 |
133 | More often than most peers in Gynecological Oncology |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Treatment | 96367 |
152 | More often than most peers in Gynecological Oncology |
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
108 | As often as other peers in Gynecological Oncology |
| Administration of additional new drug or substance into vein, 1 hour or less | Treatment | 96417 |
53 | Less often than most peers in Gynecological Oncology |
| Injection, dexamethasone sodium phosphate, 1 mg | Drug given | J1100 |
706 | As often as other peers in Gynecological Oncology |
| Blood test, comprehensive group of blood chemicals | Lab test | 80053 |
139 | As often as other peers in Gynecological Oncology |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | Office visit | 99214 |
128 | More often than most peers in Gynecological Oncology |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Lab test | 85025 |
128 | As often as other peers in Gynecological Oncology |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | Lab test | 86304 |
114 | As often as other peers in Gynecological Oncology |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | Office visit | 99213 |
57 | As often as other peers in Gynecological Oncology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Jaron E. Mark is a gynecological oncology in San Antonio, TX. That is the designation recorded for this NPI in the federal registry.
NPI registry
Jaron E. Mark is listed at 4383 Medical Dr, San Antonio, TX 78229. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (210) 593-5700. Contact the office directly to confirm availability and scheduling.
NPI registry
Jaron E. Mark's National Provider Identifier is 1073888319. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Jaron E. Mark attended Meharry Medical College School of Medicine, graduating in 2012. This comes from the CMS National Downloadable File.
CMS public data
Jaron E. Mark has 14 years experience. Calculated from a graduation year of 2012, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Jaron E. Mark performs procedures including insertion of needle into vein for collection of blood sample; provides treatments such as infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less and administration of chemotherapy into vein, 1 hour or less, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Jaron E. Mark. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.